What does RAAR mean in UNCLASSIFIED
The Rheumatoid Arthritis Azathioprine Registry (RAAR) is a resource that collects information on patients who take azathioprine, a medicine used to treat rheumatoid arthritis. The goal of the registry is to understand how best to use this medication in treating patients with RA.
RAAR meaning in Unclassified in Miscellaneous
RAAR mostly used in an acronym Unclassified in Category Miscellaneous that means Rheumatoid Arthritis Azathioprine Registry
Shorthand: RAAR,
Full Form: Rheumatoid Arthritis Azathioprine Registry
For more information of "Rheumatoid Arthritis Azathioprine Registry", see the section below.
Essential Questions and Answers on Rheumatoid Arthritis Azathioprine Registry in "MISCELLANEOUS»UNFILED"
What is the Rheumatoid Arthritis Azathioprine Registry (RAAR)?
The RAAR is a resource that collects data on the use of azathioprine, an immunomodulator drug used to treat rheumatoid arthritis. It aims to improve understanding of how this medication provides effective treatments for RA.
What type of data does the RAAR collect?
The RAAR collects information about patients' health, such as demographic facts and clinical measurements. Additionally, it catalogues which medications are prescribed and how these drugs interact with other treatments regimens.
Who is eligible for inclusion in the registry?
Patients must be 18 years or older and meet criteria for diagnosis of rheumatoid arthritis in order to be included in the registry.
How long will data collection last?
Data collection currently has no definite ending date; however, enrolment may close without warning at any time depending on resources available.
Is there confidentiality when using the registry?
Yes, patient confidentiality is strictly maintained and all data collected from the registry is securely stored. Patient identity is kept confidential throughout the duration of their participation in the registry.
Final Words:
By incorporating patient information into a central repository like the RAAR, physicians can have better access to treatments and methods for managing rheumatoid arthritis more effectively than ever before. This approach can also reduce health care costs for both patients and providers alike by increasing treatment accuracy and precision over time.